Adherence to Bronchiolitis Guidelines Cuts LOS, Costs

Share this content:
Adherence to Bronchiolitis Guidelines Cuts LOS, Costs
Adherence to Bronchiolitis Guidelines Cuts LOS, Costs

THURSDAY, Feb. 9, 2017 (HealthDay News) -- Adherence to bronchiolitis clinical pathway recommendations is associated with reduced length of stay (LOS) and costs, according to a study published online Feb. 9 in Pediatrics.

Mersine A. Bryan, M.D., from the University of Washington in Seattle, and colleagues conducted a retrospective cohort study involving 267 patients ≤24 months old diagnosed with bronchiolitis. Using a standardized scoring system, the authors assessed clinical pathway adherence for 18 quality measures obtained by medical record review. They classified level of adherence into low, middle, and high tertiles, and examined the correlation between adherence tertile and LOS and costs.

The researchers found that the mean adherence scores were 78.8, 95.0, and 89.1 for emergency department, inpatient, and combined emergency department/inpatient, respectively. Cases in the highest versus the lowest adherence tertile had significantly shorter LOS (emergency department, 90 versus 140 minutes; inpatient, 3.1 versus 3.8 days). Cases in the highest adherence tertile had significantly lower costs (emergency department, −$84; total, −$1,296). The odds of admission were lower for emergency department cases in the highest tertile (odds ratio, 0.38). There was no difference in readmission based on tertile.

"This study illustrates the importance of clinician adherence to specific pathway care processes," the authors write. "By improving adherence to evidence-based recommendations within a clinical pathway, we may be able to provide higher-value care by optimizing the quality of bronchiolitis care at lower costs and with shorter LOS."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Influenza Vaccine 48 Percent Effective Overall

CDC: Influenza Vaccine 48 Percent Effective Overall

More severe H3N2 strain a factor in reduced coverage

D.C. Zika Tests Were Flawed

D.C. Zika Tests Were Flawed

One of the issues with tests was a mathematical error

Experts Warn of Health Threats From Climate Change

Experts Warn of Health Threats From Climate Change

Additional 250,000 deaths/year projected from heat stress, malnutrition, infectious diseases

is free, fast, and customized just for you!

Already a member?

Sign In Now »